Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial.

[1]  Jingwei Shao,et al.  The Unique Pharmacological Characteristics of Mifepristone (RU486): From Terminating Pregnancy to Preventing Cancer Metastasis , 2014, Medicinal research reviews.

[2]  C. Krajewski,et al.  Cervical preparation for second-trimester surgical abortion prior to 20 weeks' gestation: SFP Guideline #2013-4. , 2014, Contraception.

[3]  A. Creanga,et al.  Abortion surveillance - United States, 2010. , 2013, Morbidity and mortality weekly report. Surveillance summaries.

[4]  M. Y. Hou,et al.  Mifepristone vs. osmotic dilator insertion for cervical preparation prior to surgical abortion at 14-16 weeks: a randomized trial. , 2011, Contraception.

[5]  N. Kapp,et al.  Clinical guidelines. Labor induction abortion in the second trimester. , 2011, Contraception.

[6]  P. Ho,et al.  Issues in second trimester induced abortion (medical/surgical methods). , 2010, Best practice & research. Clinical obstetrics & gynaecology.

[7]  C. Hammond,et al.  Dilation and Evacuation , 2009 .

[8]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[9]  M. Simon,et al.  First-trimester surgical abortion practices: a survey of National Abortion Federation members. , 2008, Contraception.

[10]  S. Newmann,et al.  Clinical guidelines. Cervical preparation for surgical abortion from 20 to 24 weeks' gestation. , 2008, Contraception.

[11]  P. Lohr,et al.  Surgical versus medical methods for second trimester induced abortion. , 2008, The Cochrane database of systematic reviews.

[12]  S. Lalitkumar,et al.  Second Trimester Medical Abortion with Mifepristone–Misoprostol and Misoprostol Alone: A Review of Methods and Management , 2008, Reproductive health matters.

[13]  E. Lichtenberg,et al.  Second-trimester surgical abortion practices: a survey of National Abortion Federation members. , 2008, Contraception.

[14]  P. Stubblefield,et al.  Mifepristone in Second-Trimester Medical Abortion: A Randomized Controlled Trial , 2007, Obstetrics and gynecology.

[15]  T. Mackenzie,et al.  Mifepristone versus laminaria: a randomized controlled trial of cervical ripening in midtrimester termination. , 2007, Contraception.

[16]  J. Carbonell,et al.  Vaginal vs. sublingual misoprostol with mifepristone for cervical priming in second-trimester abortion by dilation and evacuation: a randomized clinical trial. , 2007, Contraception.

[17]  M. Goetsch,et al.  Cervical preparation using laminaria with adjunctive buccal misoprostol before second-trimester dilation and evacuation procedures: a randomized clinical trial. , 2006, American journal of obstetrics and gynecology.

[18]  D. Grimes,et al.  Mifepristone and misoprostol versus dilation and evacuation for midtrimester abortion: a pilot randomised controlled trial , 2004, BJOG : an international journal of obstetrics and gynaecology.

[19]  P. Darney,et al.  Digoxin to Facilitate Late Second‐Trimester Abortion: A Randomized, Masked, Placebo‐Controlled Trial , 2001, Obstetrics and gynecology.

[20]  A. Templeton,et al.  Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study. , 2000, American journal of obstetrics and gynecology.

[21]  E. Baulieu.  RU 486 (Mifepristone) , 1997 .

[22]  E. Baulieu,et al.  RU486 (mifepristone): mechanisms of action and clinical uses. , 1997, Annual review of medicine.

[23]  M. Bygdeman,et al.  Mode of action of RU 486. , 1993, Annals of medicine.

[24]  R. Frydman,et al.  Efficacy of progesterone antagonist RU486 (mifepristone) for pre-operative cervical dilatation during first trimester abortion. , 1988, Human reproduction.

[25]  M. Bygdeman,et al.  Progesterone receptor blockage. Effect on uterine contractility and early pregnancy. , 1985, Contraception.